Advertisement

Erworbene Herzklappenfehler

  • D. Horstkotte

Zusammenfassung

Seit Penicillin zur Therapie und Prophylaxe von Streptokokkeninfekten breit angewandt wird, sind die sog. rheumatischen Herzklappenfehler wesentlich seltener geworden. Degenerative Herzklappenfehler — insbesondere kalzifizierende Aortenstenosen und Mitralinsuffizienz bei Funktionsstörung des subvalvulären Klappenapparates — werden dagegen parallel dem Zugewinn an allgemeiner Lebenserwartung häufiger beobachtet [16]. Nosologisch bedeutsam sind daneben infektiöse und ischämische Herzklappenfehler, Stenosen auf dem Boden kongenitaler bikuspidaler, primär nicht stenotischer Aortenklappen und myxomatöse Degenerationen der Mitralklappe. Die vielfältigen sonstigen Ursachen treten zahlenmäßig in den Hintergrund [16, 17, 32]. Als Ausdruck dieses ätiologischen Wandels hat das mittlere Alter der symptomatischen Patienten in den letzten 30 Jahren deutlich zugenommen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Acar J, Michel PL,Luxereau P, Vahanian A, Cormier B (1991) Indication for surgery in mitral regurgitation. Eur Heart J 12 [Suppl B]: 52–54PubMedCrossRefGoogle Scholar
  2. 2.
    Bernardo A, Hallhuber C, Horstkotte D (1992) Home prothrombin estimation. In: Butchart EG, Bodnar E (eds) Thrombosis, embolism and bleeding. ICR, London, pp 325–330Google Scholar
  3. 3.
    Borer JS, Hochreiter C, Rosen S (1991) Right ventricular 22. function in severe non-ischemic mitral insufficiency. Eur Heart J 12 [Suppl B]: 22–25PubMedCrossRefGoogle Scholar
  4. 4.
    Borow KM, Green LH, Mann T, Sloss LJ, Braunwald E, Collins JJ, Cohn L, Grossman W (1980) End-systolic volurne as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation. Am J Med 68: 655–663PubMedCrossRefGoogle Scholar
  5. 5.
    British Society of Haematology, British Committee for Standards in Haematology, Haemostasis and Thrombosis Task Force (1990) Guidelines on oral anticoagulation, 2nd edn. J Clin Pathol 43: 177–183.Google Scholar
  6. 6.
    Butchart EG (1991) Prosthesis-specific and patient-specific anticoagulation. In: Butchart EG, Bodnar E (eds) Thrombosis, embolism and bleeding. ICR, London, pp 293–317Google Scholar
  7. 7.
    Clyne SY, Arrighi JA, Maron BJ, Dilsizian V, Bonow RO, Cannon RO (1991) Systemic and left ventricular responses to exercise stress in asymptomatic patients with valvular aortic stenosis. Am J Cardiol 68: 1469–76.PubMedCrossRefGoogle Scholar
  8. 8.
    Coplen S, Antman EM, Berlin JA, Hewitt P, Chalmers TC (1990) Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized control trials. Circulation 82: 1100–1116CrossRefGoogle Scholar
  9. 9.
    DeFilippi CR, du Wayne W, Brickner E, Willet DL, Appleton. CP,Yancy CW, Eichhorn EJ, Grayborn PA (1995) Usefulness of dobutamin echocardiography in distinguishing severe from non severe valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 75: 191–194.Google Scholar
  10. 10.
    Espada R, Westaby St (1998) New developments in mitral valve repair. Curr Opin Cardiol 13: 80–84PubMedCrossRefGoogle Scholar
  11. 11.
    Gohlke-Bärwolf C, Acar J, Burckhardt D, Oakley C, Butchart E, Krayenbuehl P, Hall R, Bodnar E, KrzeminskaPakula M, Delahaye JP, Samama M (1993) Guidelines for prevention of thromboembolic events in valvular heart disease. J Heart Valve Dis 2: 398–410PubMedGoogle Scholar
  12. 12.
    Hirsh J, Poller L, Deykin D, Sevine M, Dalen JE (1989) Optimal therapeutic range for oral anticoagulants. Chest 95 [Suppl]:5S-11 SGoogle Scholar
  13. 13.
    Hoit BD (1991) Medical treatment of valvular heart disease. Curr Opin Cardiol 6: 207–210PubMedCrossRefGoogle Scholar
  14. 14.
    Horstkotte D (1992) Abnormal cardiac anatomy and physiology. In: Butchart EG, Bodnar E (eds) Thrombosis, embolism and bleeding. ICR, London, pp 31–69Google Scholar
  15. 15.
    Horstkotte D (1994) Lebensqualität and Optimierung der Lebensqualität nach Herzklappenersatz. In: Blum V, von der Emde J (Hrsg) Diagnostik and operative Behandlung kardialer Erkrankungen. Steinkopff, Darmstadt, pp 53–71CrossRefGoogle Scholar
  16. 16.
    Horstkotte D, Loogen F (1987) Erworbene Herzklappenfehler. Urban & Schwarzenberg, München Wien BaltimoreGoogle Scholar
  17. 17.
    Horstkotte D, Niehues R, Strauer BE (1991) Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis. Eur Heart J 12 [Suppl B]: 55–60PubMedCrossRefGoogle Scholar
  18. 18.
    Horstkotte D, Schulte HD, Bircks W, Strauer BE (1993) Unexpected findings concerning thromboembolic complications and anticoagulation after complete ten year follow-up of patients with St. Jude Medical Prostheses. J Heart Valve Dis 2: 291–301PubMedGoogle Scholar
  19. 19.
    Horstkotte D, Schulte HD, Niehues R, Klein RM, Piper C, Strauer BE (1993) Diagnostic and therapeutic considerations in acute severe mitral regurgitation: Experience in consecutive patients entering the intensive care unit with pulmonary edema. J Heart Valve Dis 2: 512–522PubMedGoogle Scholar
  20. 20.
    Ikram H, Low CJS, Crozier IG, Shirlaw T (1992) Hemodynamic effects of nitroprussid on valvular aortic stenosis. Am J Cardiol 69: 361–366PubMedCrossRefGoogle Scholar
  21. 21.
    Kalmar P, Irrgang E (1993) Cardiac surgery in Germany during 1992. A report by the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 41: 202–204CrossRefGoogle Scholar
  22. 22.
    Kalmar P, Irrgang E (1997) Cardiac surgery in Germany during 1996. A report by the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 45: 134–137CrossRefGoogle Scholar
  23. 23.
    Kleaveland JP, Reiche KN, McCarthy DM, Chandler T, Priest C, Muhammed A, Makler PT, Hirshfeld J (1986) Effects of six-month afterload reduction therapy with hydralazine in chronic aortic regurgitation. Am J Cardial 57: 1109–1113CrossRefGoogle Scholar
  24. 24.
    Krayenbuehl HP (1980) Surgery for mitral regurgitation. Repair versus valve replacement. Eur Heart J 7: 638–643Google Scholar
  25. 25.
    Letsou GV, Reordon MI (1998) Minimally invasive valve surgery. Curr Opin Cardiol 13: 105–110PubMedCrossRefGoogle Scholar
  26. 26.
    Levine HJ, Pauker StG, Salzman EW, Eckman MH (1995) Antithrombotic therapy in valvular heart disease. Chest 108:4345–4445360S–370SGoogle Scholar
  27. 27.
    Loop FD, Cosgrove DM, Stewart WJ (1991) Mitral valve repair for mitral insufficiency. Eur Heart J 12 [Suppl B]: 30–33PubMedCrossRefGoogle Scholar
  28. 28.
    Meisner JS, Keren G, Pajaro 0E, Mani A, Strom JA, Frater RWM, Luniado S, Yellin EL (1991) Atrial contribution to ventricular filling in mitral stenosis. Circulation 84: 1469–1480Google Scholar
  29. 29.
    Meschengieser SS, Fondevila CG, Frontroth J, Santarelli MT (1997) Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical heart valves. J Thorac Cardiovasc Surg 113: 910–916PubMedCrossRefGoogle Scholar
  30. 30.
    National Heart, Lung and Blood Institute Ballon Valvuloplasty Registry Participants (1992) Multicenter experience with balloon mitral commissurotomy: NHLBI Balloon Valvuloplasty Registry report on immediate and 3o-day follow-up results. Circulation 85: 448–461CrossRefGoogle Scholar
  31. 31.
    Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL, Kraft CD, Miyake-Hull CY, Schwaegler RG (1997) Prospective study of asymptomatic valvular aortic steno-sis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 95: 2262–2270PubMedCrossRefGoogle Scholar
  32. 32.
    Pape LA (1987) Pathogenesis and etiology of valvular heart disease. In: Dalen JE, Alpert JS (eds) Valvular heart disease. Little, Brown & Co., Boston Toronto:1–48Google Scholar
  33. 33.
    Piper C, Horstkotte D (1998) Intrakardiale Thrombose and konsekutive Thromboembolien bei Patienten mit Herzklappenfehlern: Prädispositionen and Konzepte zur Prävention. Z Kardiol 87 (Suppl 4): 1–6PubMedCrossRefGoogle Scholar
  34. 34.
    Reordon MI, Oury JH (1998) Evolving experience with cryopreserved mitral valve allografts. Curr Opin Cardiol 13: 85–90CrossRefGoogle Scholar
  35. 35.
    Richards AM, Nicholls MG, Ikrom H, Hamilton EJ, Richards RMD (1984) Syncops in aortic valvular stenosis. Lancet 327 [Suppl II]: 113–116Google Scholar
  36. 36.
    Rippe JM, Howe JP (1987) Acute mitral regurgitation. In: Dalen JE, Alpert JS (eds) Valvular heart disease. Little, Brown & Co., Boston Toronto, pp 151–176Google Scholar
  37. 37.
    Schwammenthal E, Vered Z, Rabinowitz B, Kaplinsky E, Feinberg S (1997) Stressechocardiography beyond coronary atery disease. Eur Heart J 18 (Suppl D): 130–137CrossRefGoogle Scholar
  38. 38.
    Smedira NG, Selman R, Cosgrove DM, McCarthy PM, Lytle BW, Taylor PC, Apperson-Hansen C, Stewart RW, Loop FD (1996) Repair of anterior leaflet prolapse: chordal transfer is superior to chordal shortening. J Thorac Cardiovasc Surg 112:287–291; Diskussion 291–292Google Scholar
  39. 39.
    Stein PD, Alpert JS, Dalen JE, Horstkotte D, Turpie AGG (1998) Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest u1: in press.Google Scholar
  40. 40.
    Stenasa M, Stenasa H, Borggrefe M, Breithardt G (1993) Supraventricular tachycardia. Current Opin Cardiol 8: 54–66CrossRefGoogle Scholar
  41. 41.
    Turpie AG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, Klimek M, Hirsh J (1993) A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 329: 524–529PubMedCrossRefGoogle Scholar
  42. 42.
    Turpie AGG, Gustensen J, Hirsh J, Nelson H, Gent M (1988) Randomized comparison of two intensities of oral anticoagulant therapy after tissue valve replacement. Lancet I: 1242–1245Google Scholar
  43. 43.
    Wilkins GT, Weyman AE, Abascal V, Block P, Palacios I (1988) Percutaneous balloon dilatation of the mitral valve: analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 60: 299–308PubMedCrossRefGoogle Scholar
  44. 44.
    Wisenbaugh T, Essop R, Rothlisberger C, Sareli P (1992) Effects of a single oral dose of captopril on left ventricular performance in severe mitral regurgitation. Am J Cardiol 69: 348–353PubMedCrossRefGoogle Scholar
  45. 45.
    Yoran C, Yellen EL, Becker RM, Gabbay S, Frater RW (1979) Mechanism of reduction of mitral regurgitation with vasodilatior therapy. Am J Cardiol 43: 773–777PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • D. Horstkotte

There are no affiliations available

Personalised recommendations